Literature DB >> 32934044

Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosis.

Charlotte Woodhouse1, Arjuna Singanayagam2, Vishal C Patel3.   

Abstract

Cirrhosis is associated with intestinal dysbiosis, with specific alterations in the gut microbiota linked to particular aetiologies and manifestations of the disease. We review the role of the gut microbiome and the importance of the intestinal barrier in cirrhosis, provide an overview of the terminology and techniques relevant to this emerging area, and discuss the latest developments in therapies targeting the gut-liver axis. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  Microbiota; cirrhosis; dysbiosis; faecal microbial transplantation; gut–liver axis

Mesh：

Year:  2020        PMID： 32934044      PMCID： PMC7539737          DOI： 10.7861/clinmed.2020-0676

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


  42 in total

1.  Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.

Authors:  Javier Fernández; Verónica Prado; Jonel Trebicka; Alex Amoros; Thierry Gustot; Reiner Wiest; Carme Deulofeu; Elisabet Garcia; Juan Acevedo; Valentin Fuhrmann; François Durand; Cristina Sánchez; Maria Papp; Paolo Caraceni; Victor Vargas; Rafael Bañares; Salvatore Piano; Martin Janicko; Agustin Albillos; Carlo Alessandria; German Soriano; Tania M Welzel; Wim Laleman; Alexander Gerbes; Andrea De Gottardi; Manuela Merli; Minneke Coenraad; Faouzi Saliba; Marco Pavesi; Rajiv Jalan; Pere Ginès; Paolo Angeli; Vicente Arroyo
Journal:  J Hepatol       Date:  2018-11-02       Impact factor: 25.083

Review 2.  Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier.

Authors:  Eric C Martens; Mareike Neumann; Mahesh S Desai
Journal:  Nat Rev Microbiol       Date:  2018-08       Impact factor: 60.633

3.  Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

Authors:  Jasmohan S Bajaj; I Jane Cox; Naga S Betrapally; Douglas M Heuman; Mitchell L Schubert; Maiyuran Ratneswaran; Phillip B Hylemon; Melanie B White; Kalyani Daita; Nicole A Noble; Masoumeh Sikaroodi; Roger Williams; Mary M E Crossey; Simon D Taylor-Robinson; Patrick M Gillevet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-25       Impact factor: 4.052

Review 4.  Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.

Authors:  Qing Cao; Cheng-Bo Yu; Shi-Gui Yang; Hong-Cui Cao; Ping Chen; Min Deng; Lan-Juan Li
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2018-02-02

5.  Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.

Authors:  Salvatore Piano; Virendra Singh; Paolo Caraceni; Rakhi Maiwall; Carlo Alessandria; Javier Fernandez; Elza Cotrim Soares; Dong Joon Kim; Sung Eun Kim; Monica Marino; Julio Vorobioff; Rita de Cassia Ribeiro Barea; Manuela Merli; Laure Elkrief; Victor Vargas; Aleksander Krag; Shivaram Prasad Singh; Laurentius Adrianto Lesmana; Claudio Toledo; Sebastian Marciano; Xavier Verhelst; Florence Wong; Nicolas Intagliata; Liane Rabinowich; Luis Colombato; Sang Gyune Kim; Alexander Gerbes; Francois Durand; Juan Pablo Roblero; Kalyan Ram Bhamidimarri; Thomas D Boyer; Marina Maevskaya; Eduardo Fassio; Hyoung Su Kim; Jae Seok Hwang; Pere Gines; Adrian Gadano; Shiv Kumar Sarin; Paolo Angeli
Journal:  Gastroenterology       Date:  2018-12-13       Impact factor: 22.682

6.  Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.

Authors:  Jasmohan S Bajaj; Chathur Acharya; Andrew Fagan; Melanie B White; Edith Gavis; Douglas M Heuman; Phillip B Hylemon; Michael Fuchs; Puneet Puri; Mitchell L Schubert; Arun J Sanyal; Richard K Sterling; Todd R Stravitz; Mohammad S Siddiqui; Velimir Luketic; Hannah Lee; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Gastroenterol       Date:  2018-06-06       Impact factor: 10.864

7.  Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.

Authors:  Jasmohan S Bajaj; Zain Kassam; Andrew Fagan; Edith A Gavis; Eric Liu; I Jane Cox; Raffi Kheradman; Douglas Heuman; Jessica Wang; Thomas Gurry; Roger Williams; Masoumeh Sikaroodi; Michael Fuchs; Eric Alm; Binu John; Leroy R Thacker; Antonio Riva; Mark Smith; Simon D Taylor-Robinson; Patrick M Gillevet
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

8.  Alterations of the human gut microbiome in liver cirrhosis.

Authors:  Nan Qin; Fengling Yang; Ang Li; Edi Prifti; Yanfei Chen; Li Shao; Jing Guo; Emmanuelle Le Chatelier; Jian Yao; Lingjiao Wu; Jiawei Zhou; Shujun Ni; Lin Liu; Nicolas Pons; Jean Michel Batto; Sean P Kennedy; Pierre Leonard; Chunhui Yuan; Wenchao Ding; Yuanting Chen; Xinjun Hu; Beiwen Zheng; Guirong Qian; Wei Xu; S Dusko Ehrlich; Shusen Zheng; Lanjuan Li
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962

9.  Intestinal fungi contribute to development of alcoholic liver disease.

Authors:  An-Ming Yang; Tatsuo Inamine; Katrin Hochrath; Peng Chen; Lirui Wang; Cristina Llorente; Sena Bluemel; Phillipp Hartmann; Jun Xu; Yukinori Koyama; Tatiana Kisseleva; Manolito G Torralba; Kelvin Moncera; Karen Beeri; Chien-Sheng Chen; Kim Freese; Claus Hellerbrand; Serene Ml Lee; Hal M Hoffman; Wajahat Z Mehal; Guadalupe Garcia-Tsao; Ece A Mutlu; Ali Keshavarzian; Gordon D Brown; Samuel B Ho; Ramon Bataller; Peter Stärkel; Derrick E Fouts; Bernd Schnabl
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 19.456

10.  The vocabulary of microbiome research: a proposal.

Authors:  Julian R Marchesi; Jacques Ravel
Journal:  Microbiome       Date:  2015-07-30       Impact factor: 14.650
View more
  1 in total

Review 1.  Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut-Liver Axis.

Authors:  Xiang Chen; Menghan Liu; Jun Tang; Ning Wang; Yibin Feng; Haotian Ma
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.